Pancreatitis risk: Patients with a history of pancreatitis should be monitored carefully, as incretin-based therapies have been associated with rare pancreatic events
That often amounted to around 58 pounds not possible, until recently, by means other than bariatric surgery
Brand-Name FDA-Approved Medications Referenced on altRx altRx's source materials also reference brand-name FDA-approved medications at separate listed price points: Mounjaro: Listed at $1,249 per month per altRx's source materials Ozempic: Listed at $1,149 per month per altRx's source materials Wegovy: Listed at $1,579 per month per altRx's source materials Zepbound: Listed at $1,249 per month per altRx's source materials According to altRx's published trademark notice, Wegovy is FDA-approved for weight loss, and Ozempic is FDA-approved for type 2 diabetes treatment but may be prescribed for weight loss at the discretion of a clinician
Verify current details directly with the platform before enrolling
If you miss two or more consecutive doses, you should contact your healthcare provider
0.67), Upper Extremity (0.63